Related Experiment Video
Updated: Jun 26, 2026

Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits
Published on: February 28, 2025
Advances in the prevention of sudden cardiac death in the young
Rhian Shephard1, Christopher Semsarian
1Signal Transduction Group, Centenary Institute, Sydney, Australia r.shephard@centenary.org.au
Insights
Sudden cardiac death (SCD) in young individuals is often caused by genetic heart disorders, not just coronary artery disease. Implantable cardioverter-defibrillators and genetic testing are key to preventing these tragic deaths and screening at-risk relatives.
Area of Science:
- Cardiology
- Genetics
- Preventive Medicine
Background:
- Sudden cardiac death (SCD) is a significant cause of mortality, particularly in younger populations (≤35 years).
- While coronary artery disease is a common cause of SCD in older adults, genetic heart disorders are increasingly recognized as primary contributors in the young.
- Existing pharmacological treatments have limited impact, highlighting the need for advanced preventive strategies.
Purpose of the Study:
- To review the causes and prevention strategies for sudden cardiac death in young individuals.
- To emphasize the role of genetic heart disorders as a major etiology of SCD in the young.
- To discuss the impact of emerging diagnostic and preventive technologies.
Main Methods:
- Review of current literature on sudden cardiac death in young individuals.
- Analysis of the role of genetic heart disorders and their inheritance patterns.
- Evaluation of the efficacy of implantable cardioverter-defibrillator (ICD) therapy and genetic testing.
Main Results:
- Genetic heart disorders are a significant cause of SCD in individuals under 35 years old.
- Implantable cardioverter-defibrillator (ICD) therapy represents a major advancement in SCD prevention for the young.
- Family screening and genetic testing are crucial for identifying at-risk individuals and enabling early diagnosis.
Conclusions:
- Understanding the genetic basis of SCD is vital for developing targeted preventive strategies.
- Genetic testing, including molecular autopsy, plays an emerging role in diagnosing underlying cardiovascular genetic disorders.
- Future research into molecular mechanisms and environmental triggers will further improve SCD prevention in young populations.
Abstract:
Sudden cardiac death (SCD) is a tragic and devastating complication of a number of cardiovascular diseases. Although coronary artery disease accounts for a majority of these deaths across all ages, many other aetiologies contribute to this problem when it occurs in the young (age < or = 35 years), where coronary artery disease is far less common. Specifically, genetic heart disorders are an important cause of SCD in the young. While pharmacological therapies have made some impact on prevention of SCD, the introduction of implantable cardioverter-defibrillator (ICD) therapy has been the single major advance in the prevention of SCD in the young. In addition, the awareness that most causes of SCD in the young are inherited, means family screening of relatives of young SCD victims allows identification of previously unrecognised at-risk individuals thereby enabling prevention of SCD in relatives. The role of genetic testing, both in living affected individuals and in the setting of a 'molecular autopsy', is emerging as a key factor in early diagnosis of an underlying cardiovascular genetic disorder. Understanding the genetic basis of SCD, investigating the molecular mechanisms that lead from the gene defect to the clinical phenotype, and elucidating the specific environmental triggers for SCD, will most likely lead to further key improvements in the prevention of SCD in the young.
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Cardiopulmonary Resuscitation III: AED Use
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Introduction Cardiac Emergencies
Cardiopulmonary Resuscitation I: Adult
Cardiomyopathy II: Dilated Cardiomyopathy
